• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM VITAMIN B12 (VB12)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM VITAMIN B12 (VB12) Back to Search Results
Model Number N/A
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/02/2025
Type of Reportable Event Malfunction
Event or Problem Description
The customer reported that an erroneously elevated vitamin b12 (vb12) result was obtained on a patient sample when using reagent lot 300 on an atellica im 1300 analyzer.The initial result was not reported to the physician(s).The customer re-centrifuged the sample and repeated on an alternate atellica analyzer and obtained the same result of >2000 pg/ml.The sample was again repeated on an alternate dimension vista instrument and obtained a result, which was considered correct and reported to the physician(s).The customer then repeated the samples after resting the sample, the results of 202, 224 were obtained on the atellica analyzer and 156 on the dimension vista instrument.These results were for troubleshooting purposes only.There are no known reports of patient intervention or adverse health consequences due to event.
 
Additional Manufacturer Narrative
A united states (us) customer reported that an erroneously elevated vitamin b12 (vb12) result was obtained on a patient sample on an atellica im 1300 analyzer.Quality control (qc) and calibration were within the acceptable range when the erroneous results were obtained.The assay's instructions for use (ifu) states the following, under interpretation of results: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." siemens is investigating the issue.
 
Additional Manufacturer Narrative
Siemens filed initial mdr 1219913-2025-00187 on (b)(6) 2025.Additional information (17-oct-2025): siemens evaluated the instrument data, and the information provided by the customer.Quality control (qc) recovered within the laboratory established ranges on the event date.Reagent issues were ruled out based on quality control (qc) recovery and calibration were within acceptable ranges.No anomalies were reported in the other patient sample testing, which demonstrated that the analyzer was performing as expected.Based on the provided data, siemens determined that the cause of the discordant result was consistent with sample integrity or quality.The presence of cellular debris, due to improper sample handling, was a plausible factor contributing to the patient's elevated vb12 result(s), which normalized upon retesting after an extended time between the sample testing.A customer bulletin titled ¿preanalytical variation and specimen integrity,¿ will be issued to the customer to enhance their understanding of preanalytical factors that may influence assay performance.Return of the patient sample for further investigation was not warranted because reported discordant result was not reproducible.A product problem was not identified.The customer is operational.Note: in section h6, the codes for investigation findings and investigation conclusions have been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM VITAMIN B12 (VB12)
Common Device Name
ATELLICA IM VITAMIN B12 (VB12)
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict ave
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
333 coney st.
registration# 1219913
east walpole MA 02032
Manufacturer Contact
varsha joshi
pritech park sez, block 11
sarjapur outer ring road
karnataka 56010-3
IN   560103
870577433
MDR Report Key23321122
Report Number1219913-2025-00187
Device Sequence Number10616474
Product Code CDD
UDI-Device Identifier00630414600277
UDI-Public(01)00630414600277(10)20351300(17)260227
Combination Product (Y/N)N
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
K993571
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/27/2026
Device Model NumberN/A
Device Catalogue Number10995714
Device Lot Number20351300
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/03/2025
Supplement Date Received by Manufacturer10/17/2025
Initial Report FDA Received Date10/17/2025
Supplement Report FDA Received Date11/07/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/27/2025
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-